These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6343858)

  • 1. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.
    Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley R; Miller JP; Province MA
    Muscle Nerve; 1983 Feb; 6(2):91-103. PubMed ID: 6343858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.
    Moxley RT; Brooke MH; Fenichel GM; Mendell JR; Griggs RC; Miller JP; Province MA; Patterson V
    Muscle Nerve; 1987 Jan; 10(1):22-33. PubMed ID: 3550455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
    Mendell JR; Griggs RC; Moxley RT; Fenichel GM; Brooke MH; Miller JP; Province MA; Dodson WE
    Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy.
    Scott OM; Hyde SA; Goddard C; Dubowitz V
    Muscle Nerve; 1982 Apr; 5(4):291-301. PubMed ID: 7099196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of early orthopaedic management in Duchenne muscular dystrophy.
    Goertzen M; Baltzer A; Voit T
    Neuropediatrics; 1995 Oct; 26(5):257-9. PubMed ID: 8552216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of benefit of allopurinol in Duchenne dystrophy.
    Mendell JR; Wiechers DO
    Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
    Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
    Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trial of isaxonine in Duchenne muscular dystrophy.
    Heckmatt JZ; Hyde SA; Gabain A; Dubowitz V
    Muscle Nerve; 1988 Aug; 11(8):836-47. PubMed ID: 3050510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K; Presterl E; Graninger W
    Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sinestrol on the course of the myodystrophic process in progressive Duchenne muscular dystrophy].
    Zavadenko NN; Kamennykh LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):41-5. PubMed ID: 2686320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
    Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
    Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial manual muscle testing in Duchenne muscular dystrophy.
    Kilmer DD; Abresch RT; Fowler WM
    Arch Phys Med Rehabil; 1993 Nov; 74(11):1168-71. PubMed ID: 8239956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
    Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
    Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
    Zatz M; Betti RT; Frota-Pessoa O
    Am J Med Genet; 1986 Jul; 24(3):549-66. PubMed ID: 3524231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment results of modified Glorion-Rideau release in Duchenne muscular dystrophy].
    Goertzen M; Baltzer A; Voit T
    Z Orthop Ihre Grenzgeb; 1995; 133(5):401-4. PubMed ID: 7491797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Duchenne muscular dystrophy. Therapeutic principles and status after 14 years].
    Hinge HH; Hein-Sørensen O
    Ugeskr Laeger; 1990 Mar; 152(13):897-900. PubMed ID: 2321304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid therapy in Duchenne muscular dystrophy].
    Kang J
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1338-40. PubMed ID: 9128400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.